Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination
Open Access
- 1 December 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 70 (4) , 589-596
Abstract
Background: SARS-CoV-2 variants continue to circulate globally, even within highly vaccinated populations. The first-generation SARS-CoV-2 vaccines elicit neutralizing immunoglobin G (IgG) antibodies that prevent severe COVID-19 but induce only weak antibody responses in mucosal tissues. There is increasing recognition that secretory immunoglobin A (SIgA) antibodies in the upper respiratory tract and oral cavity are critical in interrupting virus shedding, transmission, and progression of disease. To fully understand the immune-related factors that influence SARS-CoV-2 dynamics at the population level, it will be necessary to monitor virus-specific IgG and SIgA in systemic and mucosal compartments. Content: Oral fluids and saliva, with appropriate standardized collection methods, constitute a readily accessible biospecimen type from which both systemic and mucosal antibodies can be measured. Serum-derived IgG and immunoglobin A (IgA) are found in gingival crevicular fluids and saliva as the result of transudation, while SIgA, which is produced in response to mucosal infection and vaccination, is actively transported across salivary gland epithelia and present in saliva and passive drool. In this mini-review, we summarize the need for the implementation of standards, highly qualified reagents, and best practices to ensure that clinical science is both rigorous and comparable across laboratories and institutions. We discuss the need for a better understanding of sample stability, collection methods, and other factors that affect measurement outcomes and interlaboratory variability. Summary: The establishment of best practices and clinical laboratory standards for the assessment of SARS-CoV-2 serum and mucosal antibodies in oral fluids is integral to understanding immune-related factors that influence COVID-19 transmission and persistence within populations.Keywords
Funding Information
- National Cancer Institute (U01CA260508)
- National Institutes of Health (75N91019D00024)
This publication has 43 references indexed in Scilit:
- HPV-specific antibodies at the oral cavity up to 30 months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged menVaccine, 2019
- Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® spongesVaccine, 2018
- Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine TrialThe Journal of Infectious Diseases, 2016
- Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-ChainMonoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2016
- Secretory immunity with special reference to the oral cavityJournal of Oral Microbiology, 2013
- Sample Stability and Protein Composition of Saliva: Implications for Its Use as a Diagnostic FluidBiomarker Insights, 2008
- A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, BelgiumEuropean Journal of Epidemiology, 2007
- Do Salivary Antibodies Reliably Reflect Both Mucosal and Systemic Immunity?Annals of the New York Academy of Sciences, 2007
- Stability of total and rubella-specific IgG in oral fluid samples: the effect of time and temperatureJournal of Immunological Methods, 2002
- Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humansNature Medicine, 1998